Björk-Eriksson T - Search Results

1

Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.

Nyqvist J, Fransson P, Laurell G, Hammerlid E, Kjellén E, Franzén L, Söderström K, Wickart-Johansson G, Friesland S, Sjödin H, Brun E, Ask A, Nilsson P, Ekberg L, Björk-Eriksson T, Nyman J, Lödén B, Lewin F, Reizenstein J, Lundin E, Zackrisson B. Nyqvist J, et al. Radiother Oncol. 2016 Feb;118(2):335-41. doi: 10.1016/j.radonc.2015.12.024. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777124 Clinical Trial.

2

The in vitro radiosensitivity of human head and neck cancers.

Björk-Eriksson T, West CM, Karlsson E, Slevin NJ, Davidson SE, James RD, Mercke C. Björk-Eriksson T, et al. Br J Cancer. 1998 Jun;77(12):2371-5. doi: 10.1038/bjc.1998.394. Br J Cancer. 1998. PMID: 9649161 Free PMC article.

3

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

Björk-Eriksson T, West CM, Cvetskovska E, Svensson M, Karlsson E, Magnusson B, Slevin NJ, Edström S, Mercke C. Björk-Eriksson T, et al. Br J Cancer. 1999 Jul;80(9):1400-4. doi: 10.1038/sj.bjc.6690535. Br J Cancer. 1999. PMID: 10424742 Free PMC article.

4

MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up.

Ekholm SE, Björk-Eriksson T, Western A, Nellström H, Jonsson E, Johansson A, Lönn L, Mercke C, Tollesson PO. Ekholm SE, et al. Eur J Radiol. 2001 Sep;39(3):168-75. doi: 10.1016/s0720-048x(01)00371-0. Eur J Radiol. 2001. PMID: 11566244 Clinical Trial.

5

Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferences.

Stalfors J, Edström S, Björk-Eriksson T, Mercke C, Nyman J, Westin T. Stalfors J, et al. J Telemed Telecare. 2001;7(6):338-43. doi: 10.1258/1357633011936976. J Telemed Telecare. 2001. PMID: 11747635

6

Number of patients potentially eligible for proton therapy.

Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, Karlsson M, Zackrisson B. Glimelius B, et al. Acta Oncol. 2005;44(8):836-49. doi: 10.1080/02841860500361049. Acta Oncol. 2005. PMID: 16332591

7

The potential of proton beam radiation therapy in head and neck cancer.

Ask A, Björk-Eriksson T, Zackrisson B, Blomquist E, Glimelius B. Ask A, et al. Acta Oncol. 2005;44(8):876-80. doi: 10.1080/02841860500355991. Acta Oncol. 2005. PMID: 16332595 Review.

8

The potential of proton beam radiation for palliation and reirradiation.

Björk-Eriksson T, Ask A, Glimelius B. Björk-Eriksson T, et al. Acta Oncol. 2005;44(8):918-20. doi: 10.1080/02841860500355967. Acta Oncol. 2005. PMID: 16332602 Review.

9

"Distributed proton radiation therapy"--a new concept for advanced competence support.

Karlsson M, Björk-Eriksson T, Mattsson O, Mattsson S, Montelius A, Nilsson P, Zackrisson B. Karlsson M, et al. Acta Oncol. 2006;45(8):1094-101. doi: 10.1080/02841860600897876. Acta Oncol. 2006. PMID: 17118845

10

Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.

Hallqvist A, Rylander H, Björk-Eriksson T, Nyman J. Hallqvist A, et al. Acta Oncol. 2007;46(7):969-74. doi: 10.1080/02841860701316065. Acta Oncol. 2007. PMID: 17851846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page